The global market for Quantitative Pathology Imaging is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Quantitative Pathology Imaging market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Quantitative Pathology Imaging market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Quantitative Pathology Imaging market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Quantitative Pathology Imaging market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Quantitative Pathology Imaging players cover Leica Biosystems (Danaher), Hamamatsu Photonics, Inc., Koninklijke Philips N.V., Olympus Corporation and F. Hoffmann-La Roche Ltd., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This latest report provides a deep insight into the global Quantitative Pathology Imaging market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Quantitative Pathology Imaging market, with both quantitative and qualitative data, to help readers understand how the Quantitative Pathology Imaging market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
The study segments the Quantitative Pathology Imaging market and forecasts the market size by Type (Software and Service,), by Application (Hospitals, Clinics, Pathology Diagnostic Laboratories and Research Institutes), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Segmentation by application
Pathology Diagnostic Laboratories
Segmentation by region
Middle East & Africa
Major companies covered
Leica Biosystems (Danaher)
Hamamatsu Photonics, Inc.
Koninklijke Philips N.V.
F. Hoffmann-La Roche Ltd.
Huron Technologies International, Inc.
Chapter 1: Scope of Quantitative Pathology Imaging, Research Methodology, etc.
Chapter 2: Executive Summary, global Quantitative Pathology Imaging market size and CAGR, Quantitative Pathology Imaging market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Quantitative Pathology Imaging revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Quantitative Pathology Imaging revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Quantitative Pathology Imaging market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Leica Biosystems (Danaher), Hamamatsu Photonics, Inc., Koninklijke Philips N.V., Olympus Corporation, F. Hoffmann-La Roche Ltd., Mikroscan Technologies, Inspirata, 3DHISTECH Ltd. and Visiopharm A/S, etc.
Chapter 14: Research Findings and Conclusion